Registro:

Referencias:

• Santos, R.A., Ferreira, A.J., Verano-Braga, T., Bader, M., Angiotensinconverting enzyme 2, angiotensin-(1-7) and Mas: New players of the renin-angiotensin system (2013) J Endocrinol, 216, pp. R1-R17
• Gironacci, M.M., Cerniello, F.M., Longo Carbajosa, N.A., Goldstein, J., Cerrato, B.D., Protective axis of the renin-angiotensin system in the brain (2014) Clin Sci (Lond), 127, pp. 295-306
• Varagic, J., Ahmad, S., Nagata, S., Ferrario, C.M., ACE2: Angiotensin II/angiotensin-( 1-7) balance in cardiac and renal injury (2014) Curr Hypertens Rep, 16, p. 420
• Su, J.B., Kinins and cardiovascular diseases (2006) Curr Pharm des, 12, pp. 3423-3435
• Leeb-Lundberg, L.M., Marceau, F., Müller-Esterl, W., Pettibone, D.J., Zuraw, B.L., International union of pharmacology XLV. Classification of the kinin receptor family: From molecular mechanisms to pathophysiological consequences (2005) Pharmacol Rev, 57, pp. 27-77
• Su, J.B., Different cross-talk sites between the renin-angiotensin and the kallikrein-kinin systems (2014) J Renin Angiotensin Aldosterone Syst, 15, pp. 319-328
• Quitterer, U., AbdAlla, S., Vasopressor meets vasodepressor: The AT1-B2 receptor heterodimer (2014) Biochem Pharmacol, 88, pp. 284-290
• Paula, R.D., Lima, C.V., Britto, R.R., Campagnole-Santos, M.J., Khosla, M.C., Santos, R.A., Potentiation of the hypotensive effect of bradykinin by angiotensin-( 1-7)-related peptides (1999) Peptides, 20, pp. 493-500
• Fernandes, L., Fortes, Z.B., Nigro, D., Tostes, R.C., Santos, R.A., Catelli De Carvalho, M.H., Potentiation of bradykinin by angiotensin-(1-7) on arterioles of spontaneously hypertensive rats studied in vivo (2001) Hypertension, 37 (2), pp. 703-709
• Abbas, A., Gorelik, G., Carbini, L.A., Scicli, A.G., Angiotensin-(1-7) induces bradykinin-mediated hypotensive responses in anesthetized rats (1997) Hypertension, 30, pp. 217-221
• Li, P., Chappell, M.C., Ferrario, C.M., Brosnihan, K.B., Angiotensin-(1-7) augments bradykinin-induced vasodilation by competing with ACE and releasing nitric oxide (1997) Hypertension, 29, pp. 394-400
• Peiró, C., Vallejo, S., Gembardt, F., Palacios, E., Novella, S., Azcutia, V., Rodríguez-Mañas, L., Walther, T., Complete blockade of the vasorelaxant effects of angiotensin-(1-7) and bradykinin in murine microvessels by antagonists of the receptor Mas (2013) J Physiol, 591, pp. 2275-2285
• Gironacci, M.M., Valera, M.S., Yujnovsky, I., Peña, C., Angiotensin-(1-7) inhibitory mechanism of norepinephrine release in hypertensive rats (2004) Hypertension, 44, pp. 783-787
• Costa, M.A., Lopez Verrilli, M.A., Gomez, K.A., Nakagawa, P., Peña, C., Arranz, C., Gironacci, M.M., Angiotensin-(1-7) upregulates cardiac nitric oxide synthase in spontaneously hypertensive rats (2010) Am J Physiol Heart Circ Physiol, 299, pp. H1205-H1211
• Bomtempo, C.A., Santos, G.F., Santos, R.A., Campagnole-Santos, M.J., Interaction of bradykinin and angiotensin-(1-7) in the central modulation of the baroreflex control of the heart rate (1998) J Hypertens, 16 (12), pp. 1797-1804
• Santos, R.A., Campagnole-Santos, M.J., Baracho, N.C., Fontes, M.A., Silva, L.C., Neves, L.A., Oliveira, D.R., Gropen Júnior, C., Characterization of a new angiotensin antagonist selective for angiotensin-( 1-7): Evidence that the actions of angiotensin-(1-7) are mediated by specific angiotensin receptors (1994) Brain Res Bull, 35, pp. 293-298
• Ciruela, F., Vallano, A., Arnau, J.M., Sánchez, S., Borroto-Escuela, D.O., Agnati, L.F., Fuxe, K., Fernández-Dueñas, V., G protein-coupled receptor oligomerization for what? (2010) J Recept Signal Transduct Res, 30, pp. 322-330
• Ferré, S., Casadó, V., Devi, L.A., Filizola, M., Jockers, R., Lohse, M.J., Milligan, G., Guitart, X., G protein-coupled receptor oligomerization revisited: Functional and pharmacological perspectives (2014) Pharmacol Rev, 66, pp. 413-434
• Milligan, G., The role of dimerisation in the cellular trafficking of G-protein-coupled receptors (2010) Curr Opin Pharmacol, 10, pp. 23-29
• Gironacci, M.M., Adamo, H.P., Corradi, G., Santos, R.A., Ortiz, P., Carretero, O.A., Angiotensin (1-7) induces MAS receptor internalization (2011) Hypertension, 58, pp. 176-181
• Amaral, M.M., Sacerdoti, F., Jancic, C., Repetto, H.A., Paton, A.W., Paton, J.C., Ibarra, C., Action of Shiga toxin type-2 and subtilase cytotoxin on human microvascular endothelial cells (2013) PLoS One, 8, p. e70431
• Grecco, H.E., Bastiaens, P.I., Imaging protein states in cells (2010) Live Cell Imaging: A Laboratory Manual, 6, pp. 95-118. , Eds Goldman RD, Swedlow J, Spector D (Cold Spring Harbor Laboratory Press)
• Abd Alla, J., Reeck, K., Langer, A., Streichert, T., Quitterer, U., Calreticulin enhances B2 bradykinin receptor maturation and heterodimerization (2009) Biochem Biophys Res Commun, 387, pp. 186-190
• Kostenis, E., Milligan, G., Christopoulos, A., Sanchez-Ferrer, C.F., Heringer-Walther, S., Sexton, P.M., Gembardt, F., Walther, T., G-protein-coupled receptor Mas is a physiological antagonist of the angiotensin II type 1 receptor (2005) Circulation, 111, pp. 1806-1813
• AbdAlla, S., Lother, H., Quitterer, U., AT1-receptor heterodimers show enhanced G-protein activation and altered receptor sequestration (2000) Nature, 407, pp. 94-98
• AbdAlla, S., Lother, H., El Massiery, A., Quitterer, U., Increased AT(1) receptor heterodimers in preeclampsia mediate enhanced angiotensin II responsiveness (2001) Nat Med, 7, pp. 1003-1009
• Zhang, X., Brovkovych, V., Zhang, Y., Tan, F., Skidgel, R.A., Downregulation of kinin B1 receptor function by B2 receptor heterodimerization and signaling (2015) Cell Signal, 27, pp. 90-103
• Ueda, S., Masumori-Maemoto, S., Wada, A., Ishii, M., Brosnihan, K.B., Umemura, S., Angiotensin(1-7) potentiates bradykinin-induced vasodilatation in man (2001) J Hypertens, 19, pp. 2001-2009
• Tom, B., De Vries, R., Saxena, P.R., Danser, A.H., Bradykinin potentiation by angiotensin-(1-7) and ACE inhibitors correlates with ACE C-and N-domain blockade (2001) Hypertension, 38, pp. 95-99
• Raffai, G., Khang, G., Vanhoutte, P.M., Angiotensin-(1-7) augments endothelium-dependent relaxations of porcine coronary arteries to bradykinin by inhibiting angiotensin-converting enzyme 1 (2014) J Cardiovasc Pharmacol, 63, pp. 453-460
• Lavoie, C., Mercier, J.F., Salahpour, A., Umapathy, D., Breit, A., Villeneuve, L.R., Zhu, W.Z., Hébert, T.E., Beta 1/beta 2-adrenergic receptor heterodimerization regulates beta 2-adrenergic receptor internalization and ERK signaling efficacy (2002) J Biol Chem, 277, pp. 35402-35410
• Martínez-Pinilla, E., Rodríguez-Pérez, A.I., Navarro, G., Aguinaga, D., Moreno, E., Lanciego, J.L., Labandeira-García, J.L., Franco, R., Dopamine D2 and angiotensin II type 1 receptors form functional heteromers in rat striatum (2015) Biochem Pharmacol, 96, pp. 131-142
• Ferré, S., Baler, R., Bouvier, M., Building a new conceptual framework for receptor heteromers (2009) Nat Chem Biol, 5, pp. 131-134
• Takano, M., Matsuyama, S., Intracellular and nuclear bradykinin B2 receptors (2014) Eur J Pharmacol, 732, pp. 169-172
• Bachvarov, D.R., Houle, S., Bachvarova, M., Bouthillier, J., Adam, A., Marceau, F., Bradykinin B(2) receptor endocytosis, recycling, and down-regulation assessed using green fluorescent protein conjugates (2001) J Pharmacol Exp Ther, 297, pp. 19-26
• Gregan, B., Jürgensen, J., Papsdorf, G., Furkert, J., Schaefer, M., Beyermann, M., Rosenthal, W., Oksche, A., Ligand-dependent differences in the internalization of endothelin A and endothelin B receptor heterodimers (2004) J Biol Chem, 279, pp. 27679-27687
• Jordan, B.A., Devi, L.A., G-protein-coupled receptor heterodimerization modulates receptor function (1999) Nature, 399, pp. 697-700
• Lavoie, C., Mercier, J.F., Salahpour, A., Umapathy, D., Breit, A., Villeneuve, L.R., Zhu, W.Z., Hébert, T.E., Beta 1/beta 2-adrenergic receptor heterodimerization regulates beta 2-adrenergic receptor internalization and ERK signaling efficacy (2002) J Biol Chem, 277, pp. 35402-35410

Citas:

---------- APA ----------

---------- CHICAGO ----------

---------- MLA ----------

---------- VANCOUVER ----------